Stent Clinical Trial Taxus® and Cypher® in Diabetics

While re-intervention rates at one year were similar between arch rivals Johnson and Johnson and Boston Scientific, this study claims that Taxus® has statistically superior performance in the fast growing diabetic population.

Boston Scientific Corporation – TAXUS® Performance Superior to Cypher® in Diabetic Patients in Head-to-Head Study